Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
NCT07453004 Plonmarlimab Primary gout Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07453004 Plonmarlimab Primary gout Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
27 August 2026
NCT07453004 clinical trial report covering Plonmarlimab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07451171 Sulfamethoxazole/Trimethoprim Malnutrition Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07451171 Sulfamethoxazole/Trimethoprim Malnutrition Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
27 August 2026
NCT07451171 clinical trial report covering Sulfamethoxazole/Trimethoprim, Phase 2, endpoints, sponsor, geography, readout timing and development white spac
Read →
CTR20260647 68Ga-HX01 Soft Tissue Sarcoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
CTR20260647 68Ga-HX01 Soft Tissue Sarcoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
27 August 2026
CTR20260647 clinical trial report covering 68Ga-HX01, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07455019 Pembrolizumab Esophageal Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07455019 Pembrolizumab Esophageal Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
27 August 2026
NCT07455019 clinical trial report covering Pembrolizumab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07455604 Silver Diammine Fluoride Dental Caries Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07455604 Silver Diammine Fluoride Dental Caries Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
27 August 2026
NCT07455604 clinical trial report covering Silver Diammine Fluoride, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Read →
CTR20260550 Androtriol Cerebral Hemorrhage Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
CTR20260550 Androtriol Cerebral Hemorrhage Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
27 August 2026
CTR20260550 clinical trial report covering Androtriol, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07452601 Albumin-Bound Paclitaxel Esophageal Squamous Cell Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07452601 Albumin-Bound Paclitaxel Esophageal Squamous Cell Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
27 August 2026
NCT07452601 clinical trial report covering Albumin-Bound Paclitaxel, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07452224 STI-7349 Advanced Lung Non-Small Cell Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07452224 STI-7349 Advanced Lung Non-Small Cell Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
27 August 2026
NCT07452224 clinical trial report covering STI-7349, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07454382 Cyclophosphamide Extramedullary Disease in Multiple Myeloma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07454382 Cyclophosphamide Extramedullary Disease in Multiple Myeloma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
27 August 2026
NCT07454382 clinical trial report covering Cyclophosphamide, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07454018 Iparomlimab/Tuvonralimab Platinum-Sensitive Ovarian Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07454018 Iparomlimab/Tuvonralimab Platinum-Sensitive Ovarian Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
27 August 2026
NCT07454018 clinical trial report covering Iparomlimab/Tuvonralimab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07453368 Orelabrutinib Evans Syndrome Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07453368 Orelabrutinib Evans Syndrome Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
27 August 2026
NCT07453368 clinical trial report covering Orelabrutinib, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07455955 Olanzapine Nausea Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07455955 Olanzapine Nausea Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
27 August 2026
NCT07455955 clinical trial report covering Olanzapine, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Read →